Foster & Motley Inc. Sells 2,065 Shares of Select Medical Holdings Co. (NYSE:SEM)

Foster & Motley Inc. decreased its stake in Select Medical Holdings Co. (NYSE:SEM) by 17.0% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 10,082 shares of the health services provider’s stock after selling 2,065 shares during the period. Foster & Motley Inc.’s holdings in Select Medical were worth $352,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Hexagon Capital Partners LLC raised its position in shares of Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 645 shares during the period. Transcendent Capital Group LLC acquired a new position in shares of Select Medical in the 2nd quarter valued at $35,000. Canada Pension Plan Investment Board bought a new stake in shares of Select Medical in the 2nd quarter valued at $39,000. DekaBank Deutsche Girozentrale acquired a new stake in Select Medical during the 2nd quarter worth $60,000. Finally, GAMMA Investing LLC grew its stake in Select Medical by 52.8% in the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock valued at $70,000 after acquiring an additional 685 shares during the period. Institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM stock opened at $38.57 on Friday. The firm has a market cap of $4.99 billion, a PE ratio of 18.02, a P/E/G ratio of 1.90 and a beta of 1.42. Select Medical Holdings Co. has a 12 month low of $21.56 and a 12 month high of $40.50. The company’s fifty day simple moving average is $34.41 and its 200-day simple moving average is $34.27. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the firm earned $0.46 EPS. The business’s quarterly revenue was up 5.7% on a year-over-year basis. Equities research analysts expect that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be paid a $0.125 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 1.30%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. StockNews.com cut Select Medical from a “buy” rating to a “hold” rating in a report on Tuesday. Royal Bank of Canada increased their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday. Bank of America initiated coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective on the stock. Finally, Benchmark reissued a “buy” rating and issued a $48.00 price target on shares of Select Medical in a research note on Friday, November 1st. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Select Medical has an average rating of “Moderate Buy” and an average price target of $40.75.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.